Michael Good
Griffith University, QLD, Australia
- This delegate is presenting an abstract at this event.

Professor Michael Good AO heads the Laboratory of Vaccines for the Developing World at Griffith University’s Institute for Glycomics. His research interests are in immunity and vaccine development for malaria and Strep A. He and his team have developed candidate vaccines for both and are in Phase I clinical trials.
Presentations this author is a contributor to:
Developing a Next-Generation Vaccination Strategy Leveraging Traditional Approaches to Combat Streptococcus pyogenes (StrepA) Infections (#188)
5:30 PM
Manisha Pandey
Poster Session 1
Delineating Humoral and Cellular Immune Responses Induced by a Peptide-Based Vaccine for Protection Against Streptococcus pyogenes (#293)
5:30 PM
Despena Vedis
Poster Session 2
The longitudinal characterisation of immune responses in the Rat Autoimmune Valvulitis model enables the assessment of disease severity and the identification of biomarkers for ARF/RHD screening (#224)
5:30 PM
Rukshan Ahamed Mohamed Rafeek
Poster Session 2
Human antibodies to M-protein epitope-based vaccines demonstrate binding to Streptococcus pyogenes (StrepA) and bactericidal activity (#290)
5:30 PM
Christie T M Short
Poster Session 2